Home › Calculator › VMTHF Dividend Calculator 2026
VMTHF Dividend DRIP Calculator 2026
474.05% YieldHealthcareVenus Medtech (Hangzhou), Inc. Class H · OTC
Price: $0.42 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When VMTHF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your VMTHF snowball 📈
$10,000 in VMTHF → $255696.69M in 10 years · $17,216,189,228.75/month
About Venus Medtech (Hangzhou), Inc. Class H (VMTHF) — Dividend Analysis 2026
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company's offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Compare VMTHF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full VMTHF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open VMTHF position with:
🌍 VMTHF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold VMTHF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 474.05% | 471.25% | $47,405 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 402.94% | 400.14% | $40,294 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 379.24% | 376.44% | $37,924 / yr |
| 🇬🇧 UK ISA | 0% | 474.05% | 471.25% | $47,405 / yr |
| 🇬🇧 UK Taxable | 8.75% | 432.57% | 429.77% | $43,257 / yr |
| 🇨🇦 TFSA | 0% | 474.05% | 471.25% | $47,405 / yr |
| 🇨🇦 CA Taxable | 25% | 355.54% | 352.74% | $35,554 / yr |
| 🇦🇺 Super (pension) | 15% | 402.94% | 400.14% | $40,294 / yr |
| 🇦🇺 AU Taxable | 30% | 331.83% | 329.03% | $33,184 / yr |
| 🇩🇪 DE Taxable | 26.375% | 349.02% | 346.22% | $34,902 / yr |
| 🇫🇷 FR Taxable | 30% | 331.83% | 329.03% | $33,184 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 VMTHF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 VMTHF Dividend Payment Schedule
VMTHF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 VMTHF vs Healthcare Benchmarks
How VMTHF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VMTHF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ VMTHF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VMTHF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Venus Medtech (Hangzhou), Inc. Class H (VMTHF) is currently trading at $0.42, 95% below its 52-week high. The current dividend yield is 474.05% based on an annual payout of $2.00 per share.
VMTHF (Venus Medtech (Hangzhou), Inc. Class H) — 474.05% Dividend Yield Analysis
Venus Medtech (Hangzhou), Inc. Class H (VMTHF) is a healthcare stock currently trading at $0.42 with a dividend yield of 474.05%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (474.05%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest VMTHF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.